163 related articles for article (PubMed ID: 32349271)
1. Structure-Activity Relationship of RGD-Containing Cyclic Octapeptide and αvβ3 Integrin Allows for Rapid Identification of a New Peptide Antagonist.
Silva A; Xiao W; Wang Y; Wang W; Chang HW; Ames JB; Lam KS; Zhang Y
Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32349271
[TBL] [Abstract][Full Text] [Related]
2. Optimization of RGD-Containing Cyclic Peptides against αvβ3 Integrin.
Wang Y; Xiao W; Zhang Y; Meza L; Tseng H; Takada Y; Ames JB; Lam KS
Mol Cancer Ther; 2016 Feb; 15(2):232-40. PubMed ID: 26719578
[TBL] [Abstract][Full Text] [Related]
3. Cyclic RGD and
Panzeri S; Arosio D; Gazzola S; Belvisi L; Civera M; Potenza D; Vasile F; Kemker I; Ertl T; Sewald N; Reiser O; Piarulli U
Molecules; 2020 Dec; 25(24):. PubMed ID: 33339382
[TBL] [Abstract][Full Text] [Related]
4. Designed synthetic analogs of the α-helical peptide temporin-La with improved antitumor efficacies via charge modification and incorporation of the integrin αvβ3 homing domain.
Diao Y; Han W; Zhao H; Zhu S; Liu X; Feng X; Gu J; Yao C; Liu S; Sun C; Pan F
J Pept Sci; 2012 Jul; 18(7):476-86. PubMed ID: 22641352
[TBL] [Abstract][Full Text] [Related]
5. Toward the development of a novel non-RGD cyclic peptide drug conjugate for treatment of human metastatic melanoma.
Redko B; Tuchinsky H; Segal T; Tobi D; Luboshits G; Ashur-Fabian O; Pinhasov A; Gerlitz G; Gellerman G
Oncotarget; 2017 Jan; 8(1):757-768. PubMed ID: 27768593
[TBL] [Abstract][Full Text] [Related]
6. Bicyclic RGD Peptides with Exquisite Selectivity for the Integrin α
Bernhagen D; Jungbluth V; Quilis NG; Dostalek J; White PB; Jalink K; Timmerman P
ACS Comb Sci; 2019 Mar; 21(3):198-206. PubMed ID: 30624885
[TBL] [Abstract][Full Text] [Related]
7. Correlation between biological activity and binding energy in systems of integrin with cyclic RGD-containing binders: a QM/MM molecular dynamics study.
Xiang M; Lin Y; He G; Chen L; Yang M; Yang S; Mo Y
J Mol Model; 2012 Nov; 18(11):4917-27. PubMed ID: 22736220
[TBL] [Abstract][Full Text] [Related]
8. Radiolabeled multimeric cyclic RGD peptides as integrin alphavbeta3 targeted radiotracers for tumor imaging.
Liu S
Mol Pharm; 2006; 3(5):472-87. PubMed ID: 17009846
[TBL] [Abstract][Full Text] [Related]
9. Photocontrol of cell adhesion processes: model studies with cyclic azobenzene-RGD peptides.
Schütt M; Krupka SS; Milbradt AG; Deindl S; Sinner EK; Oesterhelt D; Renner C; Moroder L
Chem Biol; 2003 Jun; 10(6):487-90. PubMed ID: 12837381
[TBL] [Abstract][Full Text] [Related]
10. Structural basis for the interaction of isoDGR with the RGD-binding site of alphavbeta3 integrin.
Spitaleri A; Mari S; Curnis F; Traversari C; Longhi R; Bordignon C; Corti A; Rizzardi GP; Musco G
J Biol Chem; 2008 Jul; 283(28):19757-68. PubMed ID: 18480047
[TBL] [Abstract][Full Text] [Related]
11. Cyclic RGD peptidomimetics containing bifunctional diketopiperazine scaffolds as new potent integrin ligands.
Marchini M; Mingozzi M; Colombo R; Guzzetti I; Belvisi L; Vasile F; Potenza D; Piarulli U; Arosio D; Gennari C
Chemistry; 2012 May; 18(20):6195-207. PubMed ID: 22517378
[TBL] [Abstract][Full Text] [Related]
12. Radiolabeled cyclic RGD peptides as integrin alpha(v)beta(3)-targeted radiotracers: maximizing binding affinity via bivalency.
Liu S
Bioconjug Chem; 2009 Dec; 20(12):2199-213. PubMed ID: 19719118
[TBL] [Abstract][Full Text] [Related]
13. Novel cilengitide-based cyclic RGD peptides as αvβ
Meena CL; Singh D; Weinmüller M; Reichart F; Dangi A; Marelli UK; Zahler S; Sanjayan GJ
Bioorg Med Chem Lett; 2020 Apr; 30(8):127039. PubMed ID: 32094009
[TBL] [Abstract][Full Text] [Related]
14. Synthetic RGD-containing alpha-helical coiled coil peptides promote integrin-dependent cell adhesion.
Villard V; Kalyuzhniy O; Riccio O; Potekhin S; Melnik TN; Kajava AV; Rüegg C; Corradin G
J Pept Sci; 2006 Mar; 12(3):206-12. PubMed ID: 16103993
[TBL] [Abstract][Full Text] [Related]
15. Ligands for mapping alphavbeta3-integrin expression in vivo.
Schottelius M; Laufer B; Kessler H; Wester HJ
Acc Chem Res; 2009 Jul; 42(7):969-80. PubMed ID: 19489579
[TBL] [Abstract][Full Text] [Related]
16. Site-specific inhibition of integrin alpha v beta 3-vitronectin association by a ser-asp-val sequence through an Arg-Gly-Asp-binding site of the integrin.
Choi Y; Kim E; Lee Y; Han MH; Kang IC
Proteomics; 2010 Jan; 10(1):72-80. PubMed ID: 19882657
[TBL] [Abstract][Full Text] [Related]
17. Molecular dynamics reveal that isoDGR-containing cyclopeptides are true αvβ3 antagonists unable to promote integrin allostery and activation.
Ghitti M; Spitaleri A; Valentinis B; Mari S; Asperti C; Traversari C; Rizzardi GP; Musco G
Angew Chem Int Ed Engl; 2012 Jul; 51(31):7702-5. PubMed ID: 22718573
[TBL] [Abstract][Full Text] [Related]
18. Grafting aminocyclopentane carboxylic acids onto the RGD tripeptide sequence generates low nanomolar alphaVbeta3/alphaVbeta5 integrin dual binders.
Casiraghi G; Rassu G; Auzzas L; Burreddu P; Gaetani E; Battistini L; Zanardi F; Curti C; Nicastro G; Belvisi L; Motto I; Castorina M; Giannini G; Pisano C
J Med Chem; 2005 Dec; 48(24):7675-87. PubMed ID: 16302808
[TBL] [Abstract][Full Text] [Related]
19. Engineered fibronectin type III domain with a RGDWXE sequence binds with enhanced affinity and specificity to human alphavbeta3 integrin.
Richards J; Miller M; Abend J; Koide A; Koide S; Dewhurst S
J Mol Biol; 2003 Mar; 326(5):1475-88. PubMed ID: 12595259
[TBL] [Abstract][Full Text] [Related]
20. Multivalent RGD synthetic peptides as potent alphaVbeta3 integrin ligands.
Garanger E; Boturyn D; Coll JL; Favrot MC; Dumy P
Org Biomol Chem; 2006 May; 4(10):1958-65. PubMed ID: 16688341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
